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Abstract
Background: The process of bone resorption by osteoclasts is regulated by Cathepsin K, the lysosomal collagenase
responsible for the degradation of the organic bone matrix during bone remodeling. Recently, Cathepsin K was regarded as
a potential target for therapeutic intervention of osteoporosis. However, mechanisms leading to osteopenia, which is much
more common in young female population and often appears to be the clinical pre-stage of idiopathic osteoporosis, still
remain to be elucidated, and molecular targets need to be identified.
Methodology/Principal Findings: We found, that in juvenile bone the large conductance, voltage and Ca
2+-activated (BK)
K
+ channel, which links membrane depolarization and local increases in cytosolic calcium to hyperpolarizing K
+ outward
currents, is exclusively expressed in osteoclasts. In juvenile BK-deficient (BK
2/2) female mice, plasma Cathepsin K levels were
elevated two-fold when compared to wild-type littermates. This increase was linked to an osteopenic phenotype with
reduced bone mineral density in long bones and enhanced porosity of trabecular meshwork in BK
2/2 vertebrae as
demonstrated by high-resolution flat-panel volume computed tomography and micro-CT. However, plasma levels of
sRANKL, osteoprotegerin, estrogene, Ca
2+ and triiodthyronine as well as osteoclastogenesis were not altered in BK
2/2
females.
Conclusion/Significance: Our findings suggest that the BK channel controls resorptive osteoclast activity by regulating
Cathepsin K release. Targeted deletion of BK channel in mice resulted in an osteoclast-autonomous osteopenia, becoming
apparent in juvenile females. Thus, the BK
2/2 mouse-line represents a new model for juvenile osteopenia, and revealed the
BK channel as putative new target for therapeutic controlling of osteoclast activity.
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Introduction
Osteopenia, which is discussed to be the clinical pre-stage of
idiopathic osteoporosis, is characterized by a reduced bone
mineral density and changes in bone micro-architecture leading
to a higher risk for fragility fractures in juvenile females [1]. Its
prevalence in the juvenile population of western industrialized
countries is around 16 per cent and thus, osteopenia occurs more
often in young pre-menopausal females than idiopathic osteopo-
rosis, which has a prevalence of lower than one per cent in that
group [2]. Progression of osteopenia often could result in an
idiopathic osteoporosis of young females [3], characterized by
fragility fractures of long bones and vertebrae, despite of normal
hormone and vitamin levels and no other obvious reason for
fragile bones. However, mechanisms leading to osteopenia still
remain to be elucidated.
In the last decade it became apparent that potassium channels
play a predominant role in idiopathic diseases such as LQT-
syndrome, vasospastic angina pectoris, idiopathic epilepsy, epi-
sodic ataxia and paroxysmal movement disorders [4–15]. In
human, 75 potassium channel types are known [16]. The large
conductance, voltage and Ca
2+-activated (BK) K
+ channel is
unique, since this channel links membrane depolarization and
local increases in cytosolic calcium to hyperpolarizing K
+ outward
currents in many cell types [17–20].
Patch-clamp experiments using cultured chicken osteoclastic
cells [21] as well as the osteoblastic human osteosarcoma cell lines
MG-63 [22–24] and SaOS-2 [22], and the human osteogenic
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conductance Ca
2+-activated K
+ channel in these cell types in vitro,
which was assumed to be BK channel. However, its existence in
these cell-lines is discussed controversially, since the measured
single-channel conductance of this Ca
2+-activated K
+ channel-
type does not always fit with the single-channel conductance of the
BK channel. Furthermore, BK channel blockers were unable to
block the large conductance hyperpolarizing K
+ outward currents
in some cell-lines [26]. Using a specific antibody against the
carboxy-terminus of the pore-forming BK channel a-subunit [27]
in femur and tibia slices, we found BK channels to be expressed
only in osteoclasts, but not in osteoblasts or osteocytes. To study
the functional relevance of osteoclast BK channel in bone in vivo
and to evaluate its impact for juvenile osteopenia, we analyzed
juvenile female wild-type (WT) and BK-deficient (BK
2/2) mice
[17] using in vitro and in vivo assays, flat-panel volumetric computed
tomography (fpVCT) [28,29] as well as high-resolution micro-CT
(mCT).
Methods
Mice
BK channel-deficient mice (BK
2/2) generated as previously
described [17] were bred and maintained at the animal facility of
the Institute of Pharmacy, Department Pharmacology & Toxicol-
ogy, University of Tu ¨bingen, Germany. Either litter- or age-
matched six to ten weeks old female wild type (WT) and BK
2/2
mice with hybrid SV129/C57BL6 background (always F2
generation) were randomly assigned to the experimental proce-
dures with respect to the German legislation on protection of
animals. All in vivo experiments were approved by the local Ethics
Committee for Animal Research of the University of Tu ¨bingen
(approval-no.: 35/9185.81-2) and University Medical Center
Go ¨ttingen (approval-no.: T24/08).
Immunofluorescence of femur and tibia
Whole legs from 6 to 8 weeks old WT and BK
2/2 mice were
prepared, embedded in GSV1 embedding medium (Slee, Mainz,
Germany) after removing the coat, snap-frozen in liquid nitrogen-
cooled isopentane and then stored at 232uC. 12-mm-cryostat
sections (Leica CM1900) were performed and mounted on Poly-L-
Lysine (Sigma, Mu ¨nchen, Germany)-coated glass slides (Menzel,
Braunschweig, Germany). After drying for one hour at room
temperature (RT), slices were washed for 5 minutes with Tris-
buffered-saline (TBS; 50 mM Tris, 150 mM NaCl; pH 7.4) and
pre-incubated for one hour with 10% normal donkey serum
(Dianova, Hamburg, Germany) in TBST (TBS containing 1%
bovine serum albumin and 0.5% Triton X-100; pH 7.4). After
rinsing with TBS for 5 minutes, slices were incubated over night at
RT with anti-BKa674–1115 [27] in a dilution of 1:1000 in TBST,
washed three times for each 5 minutes with TBS, and incubated
for one hour with a donkey anti rabbit-IgG conjugated with Alexa
555 (Molecular Probes [Go ¨ttingen, Germany]; 1:1000 in TBST).
After rinsing (365 minutes) with TBS, slices were incubated with
DRAQ5 (Alexis Axxora [Lo ¨rrach, Germany]; 1:1000 in TBST)
for 15 minutes to visualize the cells’ nuclei, washed again in TBS
for three times 5 minutes each and were then cover-slipped in
Kaiser’s glycerine gelatine solution (Merck, Darmstadt, Germany).
The slices were stored maximally for one day at 4uC under light
protection until performing laser scanning microscopy.
For staining of Cathepsin K, cryo-sections were fixed for
5 minutes with 220uC-cold acetone at 4uC, rinsed three times for
each 5 minutes with TBS and then pre-incubated with 10%
normal donkey serum in TBST. After washing for 5 minutes with
TBS, the primary antibodies anti-BKa674–1115 (1:1000 in TBST;
[27]) and anti-Cathepsin K (1:50 in TBST; Santa Cruz,
Heidelberg, Germany) were incubated over night at room
temperature. After washing (365 minutes) with TBS, the sections
were incubated for 1 hour with an Alexa555-conjugated donkey
anti-rabbit IgG (Molecular Probes [Go ¨ttingen, Germany]; 1:1000
in TBST) and an Alexa647-conjugated donkey anti-goat IgG
(Molecular Probes [Go ¨ttingen, Germany]; 1:1000 in TBST). The
sections were washed with TBS (365 minutes) and cover-slipped
in a 1:1 mixture of TBS and glycerine (pH 8.6). Sections were
stored under light protection at 4uC for maximally one day.
Immunofluorescence was analyzed using a confocal laser scanning
microscope (BioRad MRC1000) attached to a Nikon Diaphot 300
and equipped with a krypton-argon laser.
DAB staining of femur and tibia
12-mm-cryostat sections (Leica CM1900) of long bones from 6
to 8 weeks old female WT and BK
2/2 mice were performed and
transferred on Poly-L-Lysine (Sigma-Aldrich, Mu ¨nchen, Ger-
many)-coated glass slices (Menzel, Braunschweig, Germany). The
sections were fixed with pre-chilled 2% paraformaldehyde for
5 minutes and washed with Tris-buffered saline (TBS; 50 mM
Tris, 150 mM NaCl; pH 7.4). After blocking endogenous
peroxidise activity with 0.3% H2O2/12.5% methanol in TBS for
15 minutes, sections were washed two times for each 5 minutes
with TBS and pre-incubated for one hour with 5% normal goat
serum (DAKO, Hamburg, Germany) in TBST (TBS containing
1% bovine serum albumin and 0.5% Triton X-100; pH 7.4). After
rinsing with TBS, the slices were incubated overnight with anti-
BK(674–1115) (1:250 in TBST; [27]), washed three times for each
5 minutes with TBS, and then tagged with horseradish-peroxi-
dase-conjugated goat anti-rabbit IgG (1:400 in TBST; DAKO,
Hamburg, Germany) for 2 hours. After rinsing with TBS,
immunoreactivity was visualized using the common DAB method.
The sections were covered with Kaiser’s glycerine gelatine solution
(Merck, Darmstadt, Germany) and analyzed with a Nikon Eclipse
microscope equipped with a digital camera.
Tartrate-resistant acid phosphatase 5b staining
Mice were deeply anaesthetized with intraperitoneally applied
ketamine/xylazine (100 mg/kg KG ketamine/10 mg/kg KG
xylazine) and perfused via the left cardiac ventricle with 50 ml
phosphate-buffered saline (PBS) followed by 100 ml 2% parafor-
maldehyde in PBS (2% PFA). After dissection of the coat the legs
were prepared and post-fixed for 5 days in 2% PFA at 4uC. After
washing with PBS for two consecutive days, the legs were
decalcified in 0.4 M EDTA (pH 8.0) at room temperature for
one month. Legs were washed with PBS for three days before
being embedded in paraffin. Thereafter, longitudinal serial 10 mm
sections were prepared on a SM2000 microtome (Leica, Wetzlar,
Germany), mounted on Poly-L-Lysine (Sigma)-coated glass slides
(Menzel, Braunschweig, Germany) and melted for 1 hour at 60uC.
Serial sections were used for the staining of tartrate-resistant acid
phosphatase (TRAP) using Naphthol AS-MX phosphate (Sigma,
Mu ¨nchen, Germany) as substrate and Fast Red Violet LB Salt
(Sigma, Mu ¨nchen, Germany) as coupler. After de-paraffinisation
with xylol and rehydration via a descending line of ethanol, the
sections were washed two times for 10 minutes each with 0.2 M
sodium acetate buffer and incubated for 30 minutes in Fast Red
Violet LB solution in a humidified chamber at 37uC. The Fast Red
Violet LB solution contains 0.3 mg Fast Red Violet LB Salt
(Sigma, Mu ¨nchen, Germany) per ml TRAP-buffer (17.6% 0.2 M
sodium acetate buffer, 7.4% 0.2 M glacial acetic acid solution,
10% 0.3 M sodium tartrate buffer, 0.01% Naphthol AS-MX
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(Sigma, Mu ¨nchen, Germany) in distilled water), which was
tempered at 37uC before use. After incubation slices were rinsed
with distilled water, counterstained with hematoxylin and covered
in Kaiser’s glycerine gelatine solution (Merck, Darmstadt,
Germany). In five non-overlapping pictures of interest (POI) per
slice, the number of nuclei per TRAP5b-positive cell (osteoclast)
and the apparent number of osteoclasts within these POIs were
evaluated by two independent researchers in a double-blinded
manner using the light microscope Axiovert 200 M (Zeiss, Jena,
Germany). The inter-slice interval was always 120 mm.
Enzyme-linked immunoassays
Commercial available enzyme-linked immunoassays were used
to analyze osteoprotegerin (OPG; Biozol, Eching, Germany) and
sRANKL (soluble receptor activator of NF-kB ligand; Emelca
Bioscience, Breda, Netherlands) as well as the osteoclast-derived
cysteine protease Cathepsin K (Biozol, Eching, Germany) and the
tartrate-resistant acid phosphatase 5b (TRAP5b; IDS, Frankfurt,
Germany) in plasma from juvenile 6–8 weeks old WT and BK
2/2
mice. The activity of Cathepsin K was determined by carbox-
yterminal telopeptides, the degradation product of collagen type I
(IDS, Frankfurt, Germany). We also measured the levels of
estradiol (IBL, Hamburg, Germany) and triiodothyronine (IBL,
Hamburg, Germany). All experiments were carried out according
to the manufacturer’s protocol.
Injection of recombinant murine sRANKL
2 mg recombinant murine sRANKL (R&D Systems, Wiesba-
den, Germany; dissolved in physiologically buffered saline) was
intraperitoneally injected into 5 WT and 5 BK
2/2 female mice.
Three hours later, the mice were sacrificed and CTX and
TRAP5b were measured according to the manufacturer’s protocol
in plasma samples using a commercially available enzyme-linked
immunoassay.
Measurement of Calcium in mouse plasma
This was done by a commercial service of the central laboratory
of the CRONA clinics (Tu ¨bingen, Germany) according to
standard protocol.
Flat-panel volume computed tomography (fpVCT)
fpVCT allows the in vivo acquisition of isotropic volume data sets
with a resolution of about 150 to 200 mm for high-contrast
structures such as bones. 6–8 weeks old WT and BK
2/2 female
mice were anaesthetized using a conventional isoflurane (1.5%–
2%) inhalation regime, centered on the fpVCT gantry axis of
rotation, and placed perpendicular to the z-axis of the system in
order to scan the whole mouse with one rotation. The fpVCT (GE
Global Research, Niskayuna, NY) consists of a modified circular
CT gantry and two amorphous silicon flat-panel X-ray detectors
(each with a size of 20.5620.5 cm
2) with a 102461024 matrix of
2006200-mm
2 detector elements. The fpVCT works with a step-
and-shoot acquisition mode. The standard z-coverage of one step
was 4.21 cm. All data sets were acquired with the same protocol:
1000 projection images per rotation, 8-second rotation time, 360
used detector rows, 80 kVp, and 100 mA. A modified Feldkamp
algorithm was used for image reconstruction resulting in high-
resolution volume data sets (5126512 matrix), which were
analyzed with voxtools 3.0.64 Advantage Workstation 4.2 (GE
Healthcare, Buckinghamshire, UK). To suppress digitalization
artifacts, the isotropic voxel size of reconstructed volume was
about 100 mm and therefore less than the resolution of the system.
High-resolution micro-CT (mCT)
To evaluate putative alterations in trabecular meshwork
between the two genotypes, lumbar backbones from 6–10 weeks
old WT and BK
2/2 female mice were dissected and the 4
th and
5
th lumbar vertebrae were scanned with a high-resolution mCT
eXplore Locus SP (GE Healthcare). Data sets were acquired with
the following protocol: 1000 projection images, 360u scan
technique, 5000 ms exposure time, 72 kV, 110 mA, and an
isotropic resolution of 7.5 mm. Volume data sets with a
5126512 matrix were reconstructed using the proprietary software
of the system and analyzed with a self-developed software
implementing both the thinning algorithm from Lee and co-
workers [30] and measurement tools for bone morphological
parameters [31]. Thus, the trabecular meshwork could be
evaluated in 3 dimensions (3D).
Statistical analysis
All data are given as mean 6 standard deviation (SD). Data’s
significance was evaluated using two-tailed Student’s t-test, and
values of P,0.05 were considered statistically significant.
Results
BK channel is expressed in native bone-degrading
osteoclasts
To examine the expression profile of BK channel a-subunit in
bone, we performed confocal laser scanning microscopy on native
femur and tibia slices using the purified antibody anti-BKa674–
1115 [17,27]. In WT, immune reactivity was only detected in
multi-nucleated bone cells, which were assumed to be osteoclasts,
due to their size, their location within the bone and their number
of nuclei (Figure 1). No BK channel staining was observed in
BK
2/2 bone (Figure 1B). To clearly identify these BK channel
expressing multi-nucleated cells as osteoclasts, we performed
immunohistochemistry for Cathepsin K, an osteoclast biomarker,
using a specific antibody against this lysosomal cysteine protease
(Figure 1F). Finally, immunofluorescence of native bone slices
revealed that BK channel expression was only present in
osteoclasts but not in osteoblasts nor in osteocytes (Figure 1A,
D and also Figure S1).
Increased Cathepsin K levels but normal
bone-influencing endocrinology and osteoclastogenesis
in BK
2/2 mice
This large conductance, voltage and Ca
2+-activated K
+
channel links membrane depolarization and local increases in
cytosolic calcium to hyperpolarizing K
+ outward currents,
thereby regulating Ca
2+-dependent mechanisms such as activa-
tion in many cell-types. Osteoclasts expressing BK channel are
important for bone matrix degradation and are thus, together
with bone forming osteoblasts involved in bone remodeling. To
answer the question, whether the BK channel is involved in
regulation of osteoclast activity, we analyzed Cathepsin K as
specific activity marker in plasma of juvenile WT and BK
2/2
mice. Interestingly, plasma Cathepsin K levels in the mutants
were about two-fold higher than in corresponding WT (BK
2/2:
4.2862.40 pmol/l, n=8; WT: 2.0460.77 pmol/l, n=9)
(Figure 2A), indicating that the osteoclast activity in BK
2/2
mice was enhanced in vivo.
Acitvation of osteoclasts during bone remodeling is mediated by
a variety of factors, which were derived from osteoblasts and T-
lymphocytes but also from the endocrine system. Thus, the
significantly increased plasma Cathepsin K levels in BK
2/2 mice
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derived factors and/or by alterations of the endocrine system.
Soluble receptor activator of NF-kB ligand (sRANKL) is
released from osteoblasts and their precursors as well as from T-
lymphocytes, and stimulates the RANK-receptor on osteoclasts
resulting in fusion of mono-nucleated osteoclasts and activation of
multi-nucleated osteoclasts [32–35]. Via TRAF6-NFkB- and
cFOS-signalling pathways RANKL induces nuclear factor of
activated T-lymphocytes c1 (NFATc1), which in turn regulates
osteoclastic gene expression such as of Cathepsin K and tartrate-
resistant acid phosphatase 5b (TRAP5b) [32–34]. Analyzing
plasma sRANKL by ELISA revealed no differences between
both genotypes (WT: 38.45617.40 pmol/l, n=7; BK
2/2:
44.49621.90 pmol/l, n=12), indicating that sRANKL secretion
by osteoblasts and T-lymphocytes is not influenced by targeted
deletion of BK channel (Figure 2B). Evaluating the plasma levels of
the soluble decoy receptor osteoprotegerin (OPG), which is also
secreted from osteoblasts and T-lymphocytes to prevent sRANKL
interaction with its receptor, revealed again no differences
between both genotypes (WT: 7.0964.72 pmol/l; n=8; BK
2/2:
6.3665.20 pmol/l, n=6) (Figure 2C). These findings indicate that
both osteoblast and T-lymphocyte activity is not influenced by
genetic BK channel ablation. This is in agreement with the
observation that BK channels are not expressed in native
osteoblasts and in T-lymphocytes.
It is well established that osteoclast activity and subsequent bone
remodeling is also modulated by the endocrine system of which
estradiol, the thyroid hormone triiodothyronine and glucocorti-
coids are the prominent ones. Estradiol inhibits whereas
triiodothyronine and glucocorticoids enhance osteoclast activity.
Specific ELISAs revealed no alterations of plasma estradiol (WT:
77.165.5 pmol/l, n=12; BK
2/2: 75.761.9 pmol/l, n=12) as
Figure 1. In native bone, BK channel is expressed in osteoclasts. (A) BK channel immunoreactivity (red) in chondrocytes (triangles) and large,
multi-nucleated bone cells (arrows) within intact murine wild-type tibia, whereas BK
2/2 tibia (B) lacks BK channel immunoreactivity. (C) A multi-
nucleated bone cell (red) on a bone trabecula (asterisk) of tibia. (D) Single-nucleated osteoblasts (triangles) and osteocytes do not express BK channel
in native tibia. Note, the red dot is an artificial anti-BK precipitate. (E) Magnification of a BK channel expressing multi-nucleated bone cell (red) in
intact tibia. The nuclei were stained with DRAQ5 (blue). (F) Multi-nucleated bone cells expressing BK channel (red) were identified as osteoclasts by
tagging the osteoclast-specific marker Cathepsin K (blue). Cathepsin K staining was detected in the Howship’ lacuna as well as in cytosolic vesicles.
Note, that native bone tissue shows green autofluorescence; scale bars: 100 mm (A, B), 50 mm (D), 25 mm (C, E, F).
doi:10.1371/journal.pone.0021168.g001
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2/2 mice. (A) Enhanced
plasma Cathepsin K levels in juvenile BK
2/2 mice. Statistics derived from 9 WT and 8 BK
2/2 mice. (B, C) Osteoblast-derived factors influencing
osteoclast activity were not altered in juvenile BK
2/2 mice. Statistical summary of plasma sRANKL (B) and OPG (C) from WT and BK
2/2 mice (n=6–12
per genotype). (D, E) Endocrine factors regulating osteoclast activity were not altered in juvenile BK
2/2 mice. Statistics of plasma estradiol (D) and
plasma triiodothyronine (E) from WT (n=12–17) and BK
2/2 mice (n=12–16). (F) Upper: Apparent number of osteoclasts in native BK
2/2 proximal tibia
differed not when compared to WT. Nuclei of TRAP5b-positive (purple) osteoclasts (arrow) were stained with hematoxylin (blue). Lower: Statistical
summary of osteoclast quantification in tibia. (G) Statistics of osteoclast quantification in distal femur. In the cortical and cancellous compartment of
the evaluated bones, TRAP5b-positive cells (osteoclasts) were counted by two independent persons in a double-blinded manner in five non-
overlapping pictures of interest in each of 8–10 consecutive slices with an inter-slice-interval of 120 mm. The tibiae and femurs were derived from 4
WT and 4 BK
2/2 mice. (H) Statistics of plasma Calcium in WT and BK
2/2 mice (n=9 per genotype). All data are means6SD; *P,0.05.
doi:10.1371/journal.pone.0021168.g002
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BK
2/2: 9.561.3 ng/ml, n=16) between WT and mutant
littermates (Figure 2D, E). Furthermore, in a previous study we
could demonstrate that plasma glucocorticoid levels did not differ
between the two genotypes [18]. Thus, the endocrine system
influencing bone remodeling and subsequent osteoclast activity is
not altered in BK
2/2 mice compared to their WT littermates.
These findings point to an osteoclast-autonomous phenotype being
responsible for the increased plasma Cathepsin K levels in the
mutant mice. However, the observed increased Cathepsin K levels
in BK
2/2 plasma might be due to an endogenous increased
number of osteoclasts in BK
2/2 bones. To evaluate this putative
phenomenon, we stained serial paraffin sections from proximal
tibia and distal femur for TRAP5b (Figure 2F), which is in bone an
established specific and exclusive marker for osteoclasts. Counting
TRAP5b-positive cells in five non-overlapping and randomly
choosen pictures of interest in each of 8–10 consecutive slices
(120 mm inter-slice-interval) revealed no differences in the
apparent number of TRAP5b-positive cells between both
genotypes (Figure 2F, G). To characterize putative alterations in
osteoclast precursors, we evaluated the number of nuclei per
TRAP5b-positve cell in the above mentioned sections (Figure 2F,
G). Again, no significant changes were detected indicating that
targeted deletion of BK channel in mice do not have an influence
on osteoclastogenesis. Taken together, our results suggest an
osteoclast-autonomous phenotype which is responsible for the
increased Cathepsin K plasma levels in BK
2/2 mice. However,
the increased plasma Cathepsin K in BK
2/2 mice had no
influence on their plasma Ca
2+ levels (WT: 2.2360.27 mmol/l,
n=9; BK
2/2: 2.1760.16 mmol/l, n=9) (Figure 2H), an
indicator used in clinical diagnostics for rapid bone degradation
as seen during bone metastasis.
BK channel is involved in sRANKL-mediated Cathepsin K
release in vivo
The findings presented above raised the question whether the
increased Cathepsin K level was functional operative in BK
2/2
bones. The lysosomal cysteine protease Cathepsin K is important
for the cleavage of collagen type I, the predominant organic
component of bone matrix. The plasma level of the resulting C-
terminal telopeptides (CTX) is described as clinical marker for
bone resorption and correlates well with Cathepsin K activity in
bone [36]. Determination of plasma CTX revealed an increase of
this marker peptide (CTX in BK
2/2: 44.164.6 ng/ml, n=9;
CTX in WT: 35.964.4 ng/ml, n=8) (Figure 3), and thus verified
the enhanced secreted Cathepsin K being functional operative in
BK
2/2 bones. This result supported the idea, that BK channel
might be involved in the secretion of lysosomal cysteine protease
Cathepsin K from osteoclasts, and favours the question whether in
vivo collagen type I-degradation can be still more enhanced in the
mutants in the presence of sRANKL. To test this, we applied
murine sRANKL intraperitoneally and analyzed plasma CTX
levels in WT and BK
2/2 mice three hours later (Figure 3). In WT,
we observed a significant increase in plasma CTX from
35.964.4 ng/ml (basal) up to 43.166.6 ng/ml (n=5) after
sRANKL application. In contrast to that, the plasma level of
CTX from BK
2/2 mice did not change significantly after
sRANKL application (44.761.7 ng/ml, n=5) when compared
to basal conditions (44.164.6 ng/ml), indicating that osteoclast
BK channel regulates the sRANKL-mediated secretion of
Cathepsin K in vivo. The secretion of TRAP5b in a constant rate
from osteoclasts was not influenced by BK channel ablation in vivo
(Figure S2), suggesting a functional coupling between osteoclast
BK channel activity and sRANKL-mediated Cathepsin K
secretion.
Flat-panel volumetric computed tomography (fpVCT)
demonstrated reduced bone mineral density in juvenile
BK
2/2 mice
Our findings so far demonstrated an enhanced, functional
operative Cathepsin K level due to the lack of BK channel in
osteoclasts. This suggests putative alterations in bone mineral
density (BMD) and/or trabecular meshwork formation in
juvenile mice with targeted deletion of BK channel. To evaluate
the in vivo consequences, we performed 3D high-resolution
imaging of anaesthetized WT and BK
2/2 mice by applying
fpVCT. This technique enabled us to determine changes in
BMD in living mice. According to osteoporosis diagnostic in
patients we focussed on the analysis of murine femur and tibia.
X-ray attenuation distributions were measured in Hounsfield-
units (HU) and analyzed. BMD was calculated from HU by
application of a linear function obtained from measurements of
a bone density phantom: significant changes in HU between the
two genotypes directly resemble different BMD. As shown in
Figure 4, fpVCT imaging revealed in juvenile mutant mice a
significant reduced BMD in the distal part of femur and in the
proximal part of tibia. In-detail analysis of BMD in the
m e d u l l a r yc a v i t yo ft i b i ar e v e aled significantly reduced HU in
the mutant (417622 HU, n=6) when compared to WT (45869
HU, n=4). Although fpVCT imaging suggested proximal
fractures of BK
2/2 fibulae (Figure 4), this was ruled out by
macroscopic analysis after bone maceration: BK
2/2 fibulae
were all intact, but appeared fragile at the proximal side. At this
side, the bone mineral density was so low that it could not be
detected by fpVCT. The same phenomenon was observed in
lumbar and thoracic BK
2/2 vertebrae, where the bone mineral
density detected by fpVCT was too low to have a measureable
impact within the trabecular area (BK
2/2:2 . 5 61.9 vs. WT:
060) (Figure 4B). These ‘‘low density’’ vertebrae could be due
to an increased BK
2/2 osteoclast activity and subsequent
enhanced Cathepsin K secretion, and may reflect an increased
risk for fragility fractures. These findings favour an osteopenic
phenotype in BK
2/2 mice. Since the mechanostat mechanism
in BK
2/2 bones allows vertebrae to adapt to mechanical
Figure 3. Enhanced released Cathepsin K is functional active in
juvenile BK
2/2 mice. Statistical summary of plasma level of
characteristic collagen type I-degradation product CTX under basal
conditions (ctr) and after intraperitoneal application of recombinant
murine 2 mg sRANKL (n=5–9 per genotype). Note, that CTX is a marker
for functional active Cathepsin K. All data are means6SD; *P,0.05;
**P,0.01.
doi:10.1371/journal.pone.0021168.g003
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PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e21168Figure 4. Reduced bone mineral density (BMD) in juvenile BK
2/2 mice. (A) Upper: Representative dorsal views of volume rendering of legs,
pelvic bone and backbone from a juvenile WT (left) and a BK
2/2 mouse (right), and a magnification of their leg (Middle). BMD within the bones is
reflected by a yellow-colour-scaling, whereas ‘‘yellow’’ encodes for high BMD values. Note the black gap (arrow)i nB K
2/2 fibula, and the ‘‘low-
density’’ BK
2/2 vertebrae and bones of the mouse tail (triangle), which was due to the very low BMD within that bone region; bar: 5 mm. Lower:
Statistics of Hounsfield units in medullary cavity of tibia (n=4–6 per genotype). (B) Statistical summary of ‘‘low-density’’ vertebrae apparent only in
BK
2/2 mice (n=4–6 per genotype). All data are means6SD; *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0021168.g004
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PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e21168loading by differentiating their geometry, this could explain the
finding, that the ratio between the length of 5 lumbar
vertebrae and the length of total backbone was significantly
reduced in BK
2/2 (0.346060.0155 vs. WT: 0.391560.0377)
mice (Figure 5). A putative dysregulation of the axial skeleton
development in BK
2/2 female mice could be ruled out in this
context, since the ratio of tibia length and body length were not
statistically significant b e t w e e nb o t hg e n o t y p e s( B K
2/2:
0.18660.005 vs. WT: 0.018760.002). Taken together, fpVCT
discovered osteopenia in BK
2/2 mice.
Figure 5. Osteopenic phenotype in juvenile BK
2/2 mice. Representative, non-invasive imaging with fpVCT from total backbone in a dorsal
(left) and lateral (right) view from a WT (Upper) and a BK
2/2 mouse (Middle); bar: 5 mm. Lower: Statistical summary of ratio between length of 5
lumbar vertebrae and total length of backbone (n=6 per genotype) obtained from non-invasive fpVCT imaging. All data are means6SD; *P,0.05;
**P,0.01.
doi:10.1371/journal.pone.0021168.g005
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PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e21168High resolution micro-CT (mCT) revealed reduced
trabecular density and meshwork in BK
2/2 tibiae and
vertebrae
fpVCT of backbone (see Figures 4 and 5) showed irregular and
more compact morphology of BK
2/2 lumbar vertebrae suggest-
ing a reduced trabecular density and subsequent higher porosity.
To evaluate and quantify putative alterations in trabecular micro-
architecture in BK
2/2 vertebrae we performed high-resolution
mCT from 4 juvenile WT and BK
2/2 mice each (Figure 6 and
Table S1). A region of interest (2.061.561.5 mm
3) within the
trabecular compartment of the 4
th lumbar vertebra of each
genotype was evaluated for relative bone mineral density (rBMD)
(Figure 6A, B). In the analysed BK
2/2 vertebrae the correlated
rBMD was reduced (83.2612.6%, n=4) when compared to WT
(99.967.5%, n=4). Despite the missing significance (P=0.06) in
vertebral rBMD between the two genotypes, we found a
significantly reduced bone volume (BV)/tissue volume (TV)-ratio
in BK
2/2 vertebrae (BK
2/2: 37.2261.79%, n=4 vs. WT:
51.8562.32%, n=4) (Figure 6C, D). This clinical parameter was
accompanied with a significantly reduced number of nodes
(BK
2/2: 242.5628.5, n=4 vs. WT: 334.4641.0, n=4) within
the BK
2/2 vertebral trabecular meshwork (Figure 6E) and a
reduced number of trabecles per se (BK
2/2: 221.4622.4, n=4 vs.
WT: 287.0630.6, n=4) (Figure 6F), whereas the trabecular
thickness were not significantly altered (BK
2/2: 0.2376
0.038 mm, n=4 vs. WT: 0.21360.010 mm, n=4) (Figure 6G).
Thus, these findings demonstrated a reduced trabecular meshwork
density resulting in higher porosity of BK
2/2 vertebrae, thereby
reflecting a clinical hallmark of osteopenia. This finding was in
principle confirmed in proximal BK
2/2 tibiae showing significantly
reduced bone volume of cortical and cancellous compartments
(BK
2/2: 1.65960.278 mm
3, n=4 vs. WT: 2.02460.320 mm
3,
n=4) (Figure S3). The finding that distal femurs displayed a slightly
reduced number of trabecular nodes (BK
2/2: 599.86183.8, n=4
vs. WT: 720.26213.2, n=4) and trabecles (BK
2/2: 517.26151.4,
n=4 vs. WT: 627.36175.6, n=4), whereas the bone volume (BV)/
tissue volume (TV)-ratio (BK
2/2:2 0 . 5 66.1%, n=4 vs. WT:
18.064.0%, n=4) and the trabecular thickness (BK
2/2:
0.026760.0082 mm, n=4 vs. WT: 0.023560.0066 mm, n=4)
were not statistically significant between both genotypes (Figure S4
and Table S1), are in-line with clinical observations in osteopenic
models. However, in all three analyzed BK
2/2 bone-types no
fragility fractures could be detected by mCT, indicating that juvenile
BK
2/2 mice display an osteopenia rather than an osteoporotic
phenotype.
Discussion
Our data presented in this study establishes for the first time,
that BK channels expressed in native osteoclasts control bone-
degrading activity by regulating Cathepsin K release. Targeted
deletion of BK channel in mice resulted in an osteoclast-
autonomous osteopenia, being apparent in juvenile females
displaying normal bone-influencing endocrinology and osteoclas-
togenesis, accompanied by increased plasma Cathepsin K levels,
reduced bone mineral density and enhanced porosity of trabecular
micro-architecture, but without obvious fragility fractures. Since
juvenile osteopenia could result in an idiopathic osteoporotic
phenotype, we focussed on analyzing juvenile female mice and
provided new insights leading to juvenile osteopenia: loss of BK
channel function in osteoclasts.
Immunohistochemistry of native bones using antibody anti-
BKa674–1115 revealed a BK channel expression restricted to
osteoclasts, whereas the BK channel was absent in osteoblasts and
in osteocytes of intact bone. This suggests the BK channel as a
specific biomarker to identify oestoclasts within bone. Our finding
that osteoblasts do not express BK channels seems to conflict with
electrophysiological studies using cultured osteoblasts [24], human
osteosarcoma as well as immortalized osteoblast-precursor cell
lines [22,24,25,37]. In these cell lines, a large conductance, Ca
2+-
activated K
+ outward current was recorded suggesting the
existence of BK channels. However, this was also discussed
controversially, because of the absence of the large conductance
which is typical for BK channels [22,26]. Another aspect
contributing to the discrepancy of BK channel expression in
cultured osteoblasts might be due to immortalization and the
influence of serum factors under in vitro conditions. In fact,
proteomic analysis of freshly isolated human osteoblasts from bone
biopsies and of an immortalized osteosarcoma cell line revealed
significant differences in their gene expression profiles [38]. Thus,
cultured osteoblasts and cell-lines derived thereof differ from
native osteoblasts of intact bone tissue in their BK channel
expression.
An intact balance of osteoblast-derived sRANKL and OPG is
essential for bone remodeling and subsequent for osteoclast
activity. In bone, sRANKL exhibit a dual in vivo function: first,
during osteoclastogenesis it activates the RANK-receptor on
osteoclast precursors resulting in osteoclast differentiation and
subsequent fusion to multi-nucleated osteoclasts [32–34,39].
However, BK channel ablation in mice did not influence
osteoclastogenesis as demonstrated by quantification of
TRAP5b-positive osteoclasts and their nuclei. Second, sRANKL
enhances multi-nucleated osteoclast activity promoting bone
degradation. The osteoblast-derived decoy receptor for sRANKL,
OPG, antagonizes these effects of sRANKL in bone remodeling.
Thus, both sRANKL and OPG play a predominant role in
triggering bone formation and degradation processes. An
imbalance in this fine-tuned system promotes bone diseases like
osteoporosis and osteopetrosis. This was previously demonstrated
using mouse lines lacking either sRANKL or OPG. While mice
deficient in sRANKL exhibited an osteopetrotic phenotype based
on the lack of multi-nucleated osteoclasts due to an impaired
osteoclastogenesis [40], the genetic deletion of OPG in mice
resulted in an osteoporotic phenotype associated with an enhanced
sRANKL-mediated activity of osteoclasts leading to a reduced
bone mineral density, increased porosity and increased risk for
fractures [41]. Taken together, enhanced Cathepsin K release
from BK
2/2 osteoclasts in vivo despite a normal cross-talk between
bone-forming osteoblasts and bone-degrading osteoclasts as
determined by analyzing sRANKL and OPG in plasma, and
despite a normal endocrine system influencing osteoclast activity
reflected by plasma levels of estradiol, triiodothyronine and
glucocorticoids [18], pointed to an osteoclast-autonomous osteo-
penic phenotype.
How may the BK channel activity be related to the juvenile
osteopenic phenotype? Osteoclast activity is regulated locally by
hormones, growth factors, cell-matrix and cell-cell interactions,
and mechanical stress [42]. The elevation and the decrease of
[Ca
2+]i is very closely related with osteoclastic function [43].
Osteoclasts release the lysosomal acidic hydrolase Cathepsin K to
digest the organic matrix of bone. The fusion of lysosomes with the
ruffled border membrane is a prerequisite for bone resorption.
Apparently, active osteoclasts use a Ca
2+-dependent exocytosis
machinery for Cathepsin K release [44]. For example, cytosolic
Ca
2+ increases when the osteoclasts adhere to the bone surface via
their avb3 integrin receptors and start the digestion of the
inorganic and organic matrix components. Subsequently, local
Ca
2+ concentrations increase in the resorbed area followed by a
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PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e21168Figure 6. Increased porosity of BK
2/2 vertebral trabecular meshwork. (A, B) Representative 3D reconstructions of the 4
th lumbar vertebra
obtained by high-resolution mCT (A), and corresponding statistics of relative bone mineral density (B) from juvenile WT and BK
2/2 mice (n=4). (C–F)
Representative reconstructions of a cubic region of interest (0.560.560.5 mm
3) within the trabecular meshwork of the 4
th lumbar vertebra (C), and
corresponding statistics of bone volume (BV)/tissue volume (TV)-ratio (D), number of nodes (E), trabecles (F) and trabecular thickness (G), evaluated in
three cubic regions of interest (0.560.560.5 mm
3). Bars: 1 mm (A), 500 mm (C); all data are means6SD; *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0021168.g006
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PLoS ONE | www.plosone.org 10 June 2011 | Volume 6 | Issue 6 | e21168rise of [Ca
2+]i in osteoclasts. This rise in [Ca
2+]i is accompanied by
a hyperpolarization of the plasma membrane, presumably to
maintain the driving force for sustained Ca
2+ entry [45]. As a
result, resorbing activity gradually declines and the osteoclasts turn
into non-resorbing and motile cells, which migrate and settle on a
new surface area of the bone. The functional properties of the
[Ca
2+]i rise may differ in resorbing versus non-resorbing
osteoclasts and, in addition, the [Ca
2+]i elevation process in
resorbing-state osteoclasts may not utilize the same Ca
2+ entry
pathway employed by non-resorbing osteoclasts. Several types of
K
+ and other ionic currents across the plasma membrane may
help to maintain these functions of the osteoclast and the
intracellular ion condition [46]. For an example, transport of H
+
across the ruffled border leads to hyperpolarization of the
osteoclast membrane, which would ultimately prevent further
H
+ efflux. The inwardly rectifying K
+ conductance of a Kir
channel family member allows inward movement of K
+ at
hyperpolarized potentials, and has therefore been suggested to
counteract the change in membrane potential arising from activity
of the H
+ pump [46]. On the other hand, the BK channel activity
may be involved into the transition from the resorbing to the non-
resorbing and motile state of osteoclasts, elicited by the
hyperpolarization-induced increase of [Ca
2+]i. This would imply
that BK
2/2 osteoclasts lacking the hyperpolarizing K
+ outwards
currents in response to increases of [Ca
2+]i will not easily enter into
the non-resorbing and motile state at which bone-resorbing
activity declines. Indeed, Ca
2+-activated K
+ currents have been
suggested to be involved in the regulation of osteoclast movement
and spreading on bone substrate [26]. Hyperpolarization of the
cell membrane due to BK channel activity may serve as a positive
feedback mechanism to increase Ca
2+ influx through channels of
the trp family [47]. After cessation of Ca
2+ influx the positive
feedback turns off, while the hyperpolarization due to BK channel
activity can then reduce its own activity. Taken together, we
suggest that the BK current contributes to the negative membrane
potential of about 260 mV observed in non-resorbing/motile
osteoclasts exhibiting pseudopodia but not exhibiting an actin ring
[48]. The latter is being regarded as an indicator for the
morphological and functional properties of resorbing osteoclasts.
Hence, one may speculate that BK
2/2 osteoclasts pause longer
than wild-type in the resorbing state of their resorption cycle since
their membrane potential may be similar to resorbing osteoclasts
being approximately 210 to 220 mV. In fact, K channel activity
and Ca
2+ influx as a prerequisite for cell migration has also be
shown for other cell types like mast cells [49].
Conclusively, we established the BK channel as regulator of
osteoclast activity. Targeted deletion of BK channel revealed a
juvenile osteopenia in mice accompanied with increased plasma
Cathepsin K levels, reduced bone mineral density and increased
porosity of trabecular meshworks of long bones and vertebrae, but
without obvious fragility fractures. This mouse model may be
useful to evaluate novel drug therapies for such a disorder to
prevent putative progression from osteopenia to idiopathic
osteoporosis in juvenile females.
Supporting Information
Figure S1 BK channel expression in WT, but not in
BK
2/2 osteoclasts. Immunoreactivity in the epiphysis of tibia
showed BK channel-expressing chondrocytes (triangle) and large,
multi-nucleated osteoclasts (arrow). Other bone cell-types such as
osteoblasts (area of osteoblasts is marked with an asterisk) and
osteozyts displayed no staining for BK channel protein, as well as
BK
2/2 bone sections. Bars: 100 mm.
(TIF)
Figure S2 TRAP5b secretion is not altered in BK
2/2
osteoclasts. Statistical summary of plasma level of TRAP5b
under basal conditions (ctr) and after intraperitoneal application of
recombinant murine 2 mg sRANKL (n=4–12 per genotype and
condition). Note, that TRAP5b is an osteoclast biomarker in
immunohistochemistry and a correlate for the osteoclast number
in bones. TRAP5b is released at a constant rate independent from
osteoclast activity. All data are means6SD; *P,0.05; **P,0.01.
(TIF)
Figure S3 Reduced bone volume in BK
2/2 tibia assess-
ed by mCT supported an osteopenic phenotype. Statistics
of the absolute bone volume comprising cortical and cancellous
compartments in proximal tibia from juvenile WT and BK
2/2
mice (n=4 per genotpye). All data are means6SD; *P,0.05;
**P,0.01.
(TIF)
Figure S4 Bone parameters in BK
2/2 femur assessed
by mCT are not significantly altered. Statistics of femoral
bone volume (BV)/tissue volume (TV)-ratio (A), number of nodes
(B), trabecles (C) and trabecular thickness (D), evaluated in three
cubic regions of interest (0.560.560.5 mm
3) in femurs from
juvenile WT and BK
2/2 mice (n=4 per genotype). All data are
means6SD; *P,0.05; **P,0.01.
(TIF)
Table S1 Assessment of bone parameters in juvenile
female mice using mCT. Tb.S.: trabecular segmentation; Tb.N.:
mean number of trabecular branching per trabecular node; Tb. Th.:
trabecular thickness; all data are means6SD; *P,0.05; **P,0.01.
(DOC)
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